Teva Pharmaceutical Industries Limited (FRA:TEV)

Market Cap	18.03B
Revenue (ttm)	14.16B
Net Income (ttm)	-133.69M
Shares Out	n/a
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	7.13
Dividend	n/a
Ex-Dividend Date	n/a

Volume	515
Average Volume	1,444
Open	15.55
Previous Close	15.65
Day's Range	15.25 - 15.65
52-Week Range	11.15 - 21.90
Beta	n/a
RSI	59.55
Earnings Date	Nov 5, 2025

About FRA:TEV

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 35,686
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TEV

Financial Performance

In 2024, FRA:TEV's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.

Financial numbers in USD